| About the author: |
L. P. Sarychev, I. I. Starchenko, R. B. Savchenko, Y. V. Sarychev, G. L. Pustovoyt |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
60 patients with benign prostatic hyperplasia were divided into three groups according to their clinical manifestations – compensation, subcompensation and decompensation of the urinary bladder. According to the histological examination, prolonged bladder outlet obstruction leading to progressive destructive changes in smooth muscle cells, a decrease in the specific volume of muscle tissue and a decrease in the diameter of myocytes. Urothelium damage is accompanied by a loss of the barrier function, which results in sclerotic process. Substantiation of treatment tactics in patients with benign prostatic hyperplasia should be carried out taking into account the probable morphological changes in the bladder. Untimely elimination of the obstructive component leads to a loss of detrusor contractility. The therapeutic strategy for restoring detrusor contractility is to eliminate microcirculatory disorders and correct disorders of bioenergetic processes. |
| Tags |
benign prostatic hyperplasia, decompensated urinary bladder, metabolism-corrective therapy, anticholinesterase therapy |
| Bibliography |
- Sarychev LP, Starchenko II, Savchenko RB, Sarychev YV, Pustovoit HL. Kliniko-morfolohichne obhruntuvannia likuvalnoyi taktyky u khvorykh na dobroyakisnu hiperplaziyu peredmikhurovoyi zalozy. Urolohyia. 2020; 94(3): 237–8. [in Ukrainian]
- Shormanov YS, Vorchalov MM, Ukharskyi AV. Patogeneticheskiy podkhod k lechenyiu DHPZ oslozhnennoy khronycheskoy zaderzhkoy mochy. Eksperymentalnaia i klynycheskaia urolohyia. 2014; 3: 58–64. [in Russian]
- Burkhard FC. Bosch JLHR, Cruz F, Lemack GE, Nambiar AK, Thiruchelvam N, et. al. EAU Guidelines on Urinary Incontinence in Adults. Edn. presented at the EAU Annual Congress Amsterdam, 2020. ISBN 978-94-92671-07-3. Publisher: EAU Guidelines Office. Place published: EAU Guidelines Office, Arnhem, The Netherlands. Available at: https://uroweb.org/guideline/urinary-incontinence/.
- Duran CE, Majda A, Vander-Stichele RS. Systematic review of anticholinergic risk scales in older adults. European journal of clinical pharmacology. 2013; 69(7): 1485–96. doi: 10.1007/s00228-013-1499-3.
- Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. The Journal of urology. 2018; 200(3): 612–9. doi:10.1016/j.juro.2018.05.048
- Goldstein JI, Newbury DE, Michael JR, Ritchie NW, Scott JHJ, Joy DC. Scanning electron microscopy and X-ray microanalysis. Springer. 2017: 550. doi:10.1007/978-1-4939-6679-9
- Gravas S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, et. al. EAU Guidelines on Non-Neurogenic Male LUTS Including Benign Prostatic Obstruction. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3. Publisher: EAU Guidelines Office. Place published: EAU Guidelines Office, Arnhem, The Netherlands. Available at: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/.
- Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z. Add‐on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α‐blocker treatment for lower urinary tract symptoms. BJU Іnt. 2012; 109(12): 1831-40. doi:10.1111/j.1464-410X.2011.10624.x
- Mayer EK, Kroeze SG, Chopra S, Bottle A, Patel A. Examining the ‘gold standard’: a comparative critical analysis of three consecutive decades of monopolar transuretheral resection of the prostate (TURP) outcomes. BJU Int. 2012; 110(11): 1595–601. doi:10.1111/j.1464-410X.2012.11119.x
- Nepomnyashchikh LM, Lushnikova EL, Neimark AI. Remodeling of the muscle layer (detrusor muscle) of hyperactive bladder disease in patients with benign prostatic hyperplasia. Bulletin ofexperimental biology and medicine. 2012; 153(5): 778–83. doi:10.1007/s10517-012-1825-2
- Nishtala PS, Mohammed SS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert opinion on drug safety. 2016 15(6): 753–68. doi:10.1517/14740338.2016.1165664;
- Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int. 2015; 115(4): doi:508–19. doi:10.1111/bju.12745
|
| Publication of the article |
«World of Medicine and Biology» №2(76), 2021 year, 132-135 pages, index UDK 616.65-007.61-036-06:616.62-091:616-08-048.34 |
| DOI |
10.26724/2079-8334-2021-2-76-132-135 |
